APRE Competitors & Alternatives
Compare Aprea Therapeutics Inc with similar stocks in the same industry
Biotechnology
APRE
Main Stock$0.84
Tradestie Score
25
Market Cap
$8.50M
Revenue Growth
-1.0%
Analyst Upside
+323.3%
Top Competitors
243 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.04
|
$114.01M | - | 47 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$35.13
|
$110.20M | - | 34 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.80
|
$97.42M | - | 53 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$5.47
|
$85.47M | - | 48 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.03
|
$84.52M | - | 40 | Compare |
|
BYSI
BeyondSpring Inc. Ordinary Shares
|
$0.67
|
$72.18M | - | 43 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.09
|
$71.32M | - | 49 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.94
|
$67.94M | - | 31 | Compare |
|
CYCN
Cyclerion Therapeutics, Inc. Common Stock
|
$3.79
|
$7.59M | - | 49 | Compare |
|
ATXI
ATXI
|
- | - | - | - | Compare |
More APRE Analysis
Data updated: Aug 30, 2026 | Industry: Biotechnology (SIC 2834)
243 stocks in this industry